Presentation is loading. Please wait.

Presentation is loading. Please wait.

Localized bullous fixed drug eruption following yellow fever vaccine

Published byBarnard Bridges Modified over 6 years ago

Similar presentations

Presentation on theme: "Localized bullous fixed drug eruption following yellow fever vaccine"— Presentation transcript:

1 Localized bullous fixed drug eruption following yellow fever vaccine
Eric Y. Sako, BS, Ashley Rubin, MD, Lorraine C. Young, MD  Journal of the American Academy of Dermatology  Volume 70, Issue 5, Pages e113-e114 (May 2014) DOI: /j.jaad Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Bullous fixed drug eruption: Erythematous circular superficial erosion with desquamative scale overlying left nasal ala. Journal of the American Academy of Dermatology  , e113-e114DOI: ( /j.jaad ) Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Localized bullous fixed drug eruption following yellow fever vaccine"

Similar presentations

Use of the diagonal mattress suture to prevent dog-ear formation

Use of the diagonal mattress suture to prevent dog-ear formation
Clavi syphilitici–an unusual presentation of syphilis

Clavi syphilitici–an unusual presentation of syphilis
Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH 

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH 
A 52-year-old man with bullous pemphigoid and bullous cystitis

A 52-year-old man with bullous pemphigoid and bullous cystitis
A girl with a solitary red bulla

A girl with a solitary red bulla
Facial adenocarcinoma treated with intra-arterial chemotherapy

Facial adenocarcinoma treated with intra-arterial chemotherapy
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.

Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients  Lucy Y. Liu, BA, Brittany.
Blaschkoid pityriasis rosea

Blaschkoid pityriasis rosea
Baldness reversed by chemotherapy

Baldness reversed by chemotherapy
Chronic bullous disease of childhood and pneumonia in a neonate with VATERL association and hypoplastic paranasal sinuses  Charissa Mia D. Salud, MD,

Chronic bullous disease of childhood and pneumonia in a neonate with VATERL association and hypoplastic paranasal sinuses  Charissa Mia D. Salud, MD,
Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 
Miliarial gout: A rare clinical presentation

Miliarial gout: A rare clinical presentation
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
Sarah Sung, MD, Alexa B. Kimball, MD, MPH 

Sarah Sung, MD, Alexa B. Kimball, MD, MPH 
Rajiv I. Nijhawan, BS, Shalu S

Rajiv I. Nijhawan, BS, Shalu S
Trigeminal trophic syndrome secondary to recurrent meningioma

Trigeminal trophic syndrome secondary to recurrent meningioma
A generalized fixed drug eruption associated with mycophenolate

A generalized fixed drug eruption associated with mycophenolate
Clindamycin-induced Sweet syndrome

Clindamycin-induced Sweet syndrome
2 Lt Dane Dicaro, BS, Capt Casey Bowen, MD, LTC Scott R. Dalton, DO 

2 Lt Dane Dicaro, BS, Capt Casey Bowen, MD, LTC Scott R. Dalton, DO 

Similar presentations

Ads by Google